LifeStance Health LFST
$13.82 +$0.48 (+3.60%)
Market closed · Nov 22, 5:30 am ET · Last extended-hours $13.19 -4.59%
Open$13.21
Prev close$13.34
Day range$13.21 – $13.83
Volume5.62M
Market cap$5.25B
P/E (TTM)76.8
Dividend yield–
Fundamentals
Latest reported quarter: Q3, ended Sep 2026
Revenue$455.86M+25.3% YoY
Operating profit$33.08M+346.4% YoY
Net profit$22.39M+1,978.5% YoY
Diluted EPS$0.06
Free cash flow$22.36M+31.6% YoY
Operating cash flow$37.02M
Revenue, last 8 quarters
Net profit, last 8 quarters
Diluted EPS by quarter
Free cash flow by quarter
Annual revenue
Profitability & balance sheet
Gross margin34.4%
Operating margin6.2%
Net margin4.3%
Return on equity4.8%
Return on assets3.3%
Return on invested capital4.1%
Current ratio1.44
Liabilities / assets31.7%
Cash & investments$218.82M
Total debt$415.98M
Net cash (debt)-$197.16M
Free cash flow / sales10.7%
Where the revenue comes from
Quarter 2026/Q3
By business line
Income statement
| Line item | 2026 Q3 | 2026 Q2 | 2026 Q1 | 2025 ANNUAL | 2025 Q4 |
|---|---|---|---|---|---|
| Total Revenue as Reported | $455.86M | $435.35M | $403.48M | $1.42B | $382.20M |
| Total Operating Revenue | $455.86M | $435.35M | $403.48M | $1.42B | $382.20M |
| Cost of Revenue | $294.46M | $282.31M | $267.54M | $963.19M | $255.90M |
| Gross Profit | $161.40M | $153.04M | $135.93M | $461.10M | $126.30M |
| Operating Expense | $128.33M | $122.39M | $113.65M | $436.95M | $108.21M |
| Selling and Admin Expenses | $113.39M | $108.14M | $100.33M | $382.20M | $94.78M |
| -General & Admin Expense | $113.39M | $108.14M | $100.33M | $382.20M | $94.78M |
| Depreciation & Amortization & Depletion | $14.94M | $14.25M | $13.32M | $54.75M | $13.43M |
| -Depreciation & Amortization | $14.94M | $14.25M | $13.32M | $54.75M | $13.43M |
| Operating Profit | $33.08M | $30.65M | $22.28M | $24.15M | $18.08M |
| Net Non-Operating Interest Income (Expense) | -$2.49M | -$2.63M | -$1.79M | -$11.66M | -$2.88M |
| Non-Operating Interest Expense | $2.49M | $2.63M | $1.79M | $11.66M | $2.88M |
| Other Income (Expense) | -$3.18M | -$564,000.00 | -$731,000.00 | -$123,000.00 | -$6,000.00 |
| Special Income (Charges) | -$2.85M | -$471,000.00 | -$549,000.00 | $0.00 | $0.00 |
| -Less:Restructuring and Mergern & Acquisition | $2.85M | $471,000.00 | $549,000.00 | $0.00 | $0.00 |
| Other Non-Operating Income (Expenses) | -$334,000.00 | -$93,000.00 | -$182,000.00 | -$123,000.00 | -$6,000.00 |
| Pretax Profit | $27.40M | $27.46M | $19.76M | $12.36M | $15.20M |
| Tax | $5.02M | $3.85M | $5.52M | $2.70M | $3.54M |
| Net Profit | $22.39M | $23.61M | $14.24M | $9.66M | $11.67M |
| Profit from Continuing Operations | $22.39M | $23.61M | $14.24M | $9.66M | $11.67M |
| Net Income to Parent Company | $22.39M | $23.61M | $14.24M | $9.66M | $11.67M |
| Net Income to Common Stockholders | $22.39M | $23.61M | $14.24M | $9.66M | $11.67M |
| Basic EPS | $0.06 | $0.06 | $0.04 | $0.03 | $0.04 |
| Diluted EPS | $0.06 | $0.06 | $0.04 | $0.02 | $0.03 |
Balance sheet
| Line item | 2026 Q3 | 2026 Q2 | 2026 Q1 | 2025 ANNUAL | 2025 Q4 |
|---|---|---|---|---|---|
| Total Assets | $2.19B | $2.18B | $2.15B | $2.20B | $2.20B |
| Total Current Assets | $376.78M | $377.97M | $355.91M | $416.20M | $416.20M |
| Cash and Cash Equivalents & Short-Term Investments | $218.82M | $225.94M | $194.80M | $248.64M | $248.64M |
| -Cash and Cash Equivalents | $218.82M | $225.94M | $194.80M | $248.64M | $248.64M |
| Receivables | $120.94M | $110.96M | $122.92M | $99.50M | $99.50M |
| -Accounts Receivable | $120.94M | $110.96M | $122.92M | $95.71M | $95.71M |
| Other Current Assets | $37.02M | $41.06M | $38.20M | $19.93M | $19.93M |
| Total Non-Current Assets | $1.81B | $1.80B | $1.79B | $1.79B | $1.79B |
| Net PPE | $328.82M | $321.70M | $312.99M | $311.30M | $311.30M |
| -Gross PPE | $487.55M | $471.36M | $453.20M | $443.38M | $443.38M |
| -Accumulated Depreciation | -$158.73M | -$149.66M | -$140.20M | -$132.07M | -$132.07M |
| Goodwill and Other Intangible Assets | $1.48B | $1.48B | $1.47B | $1.47B | $1.47B |
| -Goodwill | $1.31B | $1.30B | $1.30B | $1.29B | $1.29B |
| -Other Intangible Assets | $170.04M | $172.81M | $175.14M | $177.67M | $177.67M |
| Other Non-Current Assets | $5.25M | $4.47M | $4.84M | $5.42M | $5.42M |
| Total Liabilities | $693.89M | $704.35M | $668.47M | $682.92M | $682.92M |
| Total Current Liabilities | $261.13M | $274.75M | $239.73M | $251.96M | $251.96M |
| Payables | $5.50M | $11.05M | $4.29M | $18.85M | $18.85M |
| -Accounts Payable | $5.50M | $11.05M | $4.29M | $18.85M | $18.85M |
| Current Accrued Expenses | $189.95M | $198.87M | $169.71M | $172.78M | $172.78M |
| Short-Term Debt and Capital Lease Obligation | $45.04M | $46.50M | $47.37M | $60.04M | $60.04M |
| -Current Capital Lease Obligation | $45.04M | $46.50M | $47.37M | $45.54M | $45.54M |
| Other Current Liabilities | $20.64M | $18.33M | $18.36M | $282,000.00 | $282,000.00 |
| Total Non-Current Liabilities | $432.76M | $429.60M | $428.73M | $430.96M | $430.96M |
| Long Term Debt and Capital Lease Obligation | $415.98M | $413.15M | $411.28M | $414.48M | $414.48M |
| -Long Term Debt | $255.52M | $258.99M | $262.46M | $265.93M | $265.93M |
| -Long Term Capital Lease Obligation | $160.46M | $154.16M | $148.82M | $148.55M | $148.55M |
| Non-Current Deferred Liabilities | $16.41M | $16.41M | $16.41M | $16.41M | $16.41M |
| Other Non-Current Liabilities | $373,000.00 | $37,000.00 | $1.05M | $68,000.00 | $68,000.00 |
| Total Equity | $1.49B | $1.48B | $1.48B | $1.52B | $1.52B |
| Stockholders' Equity | $1.49B | $1.48B | $1.48B | $1.52B | $1.52B |
| Capital Stock | $3.80M | $3.82M | $3.88M | $3.88M | $3.88M |
| -Common Stock | $3.80M | $3.82M | $3.88M | $3.88M | $3.88M |
| Additional Paid-In Capital | $2.24B | $2.24B | $2.27B | $2.33B | $2.33B |
| Retained Earnings | -$748.39M | -$770.77M | -$794.38M | -$808.63M | -$808.63M |
| -Preferred Stock | – | – | $0.00 | $0.00 | $0.00 |
| -Other Receivables | – | – | – | $3.79M | $3.79M |
| Prepaid Assets | – | – | – | $48.13M | $48.13M |
| -Current Debt | – | – | – | $14.50M | $14.50M |
| Gains/Losses Not Affecting Retained Earnings | – | – | – | $0.00 | $0.00 |
Cash flow
| Line item | 2026 Q3 | 2026 Q2 | 2026 Q1 | 2025 ANNUAL | 2025 Q4 |
|---|---|---|---|---|---|
| Operating Cash Flow | $37.02M | $99.91M | $33.11M | $146.15M | $57.56M |
| Net cash flow from continuing operations | $37.02M | $99.91M | $33.11M | $146.15M | $57.56M |
| Net Income from Continuing Operations | $22.39M | $23.61M | $14.24M | $9.66M | $11.67M |
| Depreciation & Depletion & Amortization | $14.94M | $14.25M | $13.32M | $54.75M | $13.43M |
| Other Non-Cash Items | $14.36M | $12.35M | $11.10M | $44.96M | $11.49M |
| Change in Working Capital | -$32.83M | $29.95M | -$20.75M | -$40.34M | $1.84M |
| -Change in Receivables | -$9.98M | $12.55M | -$26.95M | $36.09M | $25.36M |
| -Change in Prepaid Assets | $2.74M | -$2.97M | $33.78M | -$46.69M | -$36.28M |
| -Change in Payables and Accrued Expense | -$14.01M | $32.95M | -$17.62M | $18.38M | $25.06M |
| -Change in Other Current Liabilities | -$11.58M | -$12.58M | -$9.96M | -$48.13M | -$12.30M |
| Net cash flow from investing | -$15.21M | -$17.89M | -$13.91M | -$36.13M | -$10.91M |
| Net Cash Flow from Continuing Investing Activities | -$15.21M | -$17.89M | -$13.91M | -$36.13M | -$10.91M |
| Net PPE Purchase and Sale | -$14.65M | -$11.99M | -$10.77M | -$36.13M | -$10.91M |
| Net Business Purchase and Sale | -$552,000.00 | -$5.89M | -$3.14M | $0.00 | $0.00 |
| Financing Cash Flow | -$28.94M | -$50.88M | -$73.04M | -$15.96M | -$1.91M |
| Net Cash Flow from Continuing Financing Activities | -$28.94M | -$50.88M | -$73.04M | -$15.96M | -$1.91M |
| Net Issuance Payments Of Debt | -$3.63M | -$7.25M | $0.00 | -$7.25M | -$1.81M |
| Net Common Stock Issuance | -$24.81M | -$48.52M | -$49.11M | – | – |
| Proceeds from Stock Option Exercised | $0.00 | – | – | – | – |
| Net Other Financing Charges | -$505,000.00 | -$478,000.00 | -$23.94M | -$8.71M | -$98,000.00 |
| Ending Cash Balance | $218.82M | $225.94M | $194.80M | $248.64M | $248.64M |
| Net Change in Cash | -$7.13M | $31.15M | -$53.85M | $94.07M | $44.74M |
| Beginning Cash Balance | $225.94M | $194.80M | $248.64M | $154.57M | $203.90M |
| Free Cash Flow | $22.36M | $87.92M | $22.34M | $110.03M | $46.65M |
| Deferred Tax | – | – | – | $2.42M | – |
No comments yet — be the first to weigh in on LFST.
Sign in to join the discussion.